Biallelic variants in COX18 cause a mitochondrial disorder primarily manifesting as peripheral neuropathy
Brain · 2026
DOI: 10.1093/brain/awaf300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2026. Verfasst von Camila Armirola-Ricaurte und 19 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Neurogenomics Group, VIB Center for Molecular Neurology, VIB, Antwerp 2610, Belgium. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Mitochondrial Diseases, Charcot-Marie-Tooth Disease, Mitochondrial Proteins. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charcot Marie Tooth Association, Medical Research Council, NINDS NIH HHS.
Abstract (Originalsprache)
Defects in mitochondrial dynamics are a common cause of Charcot–Marie–Tooth disease (CMT), whereas primary deficiencies in the mitochondrial respiratory chain (MRC) are rare and atypical for this aetiology. This study aims to report COX18 as a novel CMT-causing gene. This gene encodes an assembly factor of mitochondrial Complex IV that translocates the C-terminal tail of MTCO2 across the mitochondrial inner membrane. Exome sequencing was performed in four affected individuals from three families. The patients and available family members underwent thorough neurological and electrophysiological assessment. The impact of one of the identified variants on splicing, protein levels and mitochondrial bioenergetics was investigated in patient-derived lymphoblasts. The functionality of the mutant protein was assessed using a proteinase K protection assay and immunoblotting. Neuronal relevance of COX18 was assessed in a Drosophila melanogaster knockdown model. Exome sequencing coupled with homozygosity mapping revealed a homozygous splice variant c.435–6A>G in COX18 in two siblings with early-onset progressive axonal sensorimotor peripheral neuropathy. By querying external databases, we identified two additional families with rare deleterious biallelic variants in COX18. All eight affected individuals presented with axonal CMT, and some patients also exhibited CNS symptoms, such as dystonia and spasticity. Functional characterization of the c.435-6A>G variant demonstrated that it leads to the expression of an alternative transcript that lacks exon 2, resulting in a stable but defective COX18 isoform. The mutant protein impairs Complex IV assembly and activity, leading to a reduction in mitochondrial membrane potential. Downregulation of the COX18 homologue in D. melanogaster resulted in signs of neurodegeneration, including locomotor deficit and progressive axonal degeneration of sensory neurons. Our study presents genetic and functional evidence that supports COX18 as a newly identified gene candidate for autosomal recessive axonal CMT with or without CNS involvement. These findings emphasize the significance of peripheral neuropathy within the spectrum of primary mitochondrial disorders, in addition to the role of mitochondrial Complex IV in the development of CMT. Our research has important implications for the diagnostic work-up of CMT patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Neurogenomics Group, VIB Center for Molecular Neurology, VIB, Antwerp 2610, Belgium.
- Molecular Neurogenomics Group, Department of Biomedical Sciences, University of Antwerp, Antwerp 2610, Belgium.
- Laboratory of Hepatology, Department of Chronic Diseases, Metabolism and Ageing, Katholieke Universiteit Leuven, Leuven 3000, Belgium.
- Department of Pediatrics, University Hospitals Leuven, Leuven 3000, Belgium.
- Department of Neurology and Psychiatry, Assiut University Hospitals, Assiut 2074020, Egypt.
- Centre for Neuromuscular Diseases, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
ORCID-Profile: Camila Armirola-Ricaurte, Menelaos Pipis, Stephanie Efthymiou, Liedewei Van de Vondel, Stephan Zuchner, Henry Houlden, Michael P Lunn, Mary M Reilly
Förderung
- Charcot Marie Tooth Association
- Medical Research Council
- NINDS NIH HHS
- National Institutes of Neurological Diseases and Stroke and office of Rare Diseases
- European Union Seventh Framework Programme
- Wellcome Trust
- European Union's Horizon 2020 research and innovation programme
- the National Institute for Health Research University College London Hospitals Biomedical Research Centre
Zitieren
APA
Armirola-Ricaurte, C., Morant, L., Adant, I., Hamed, S. A., Pipis, M., Efthymiou, S., Amor-Barris, S., Atkinson, D., Van de Vondel, L., Tomic, A., Seneca, S., de Vriendt, E., Zuchner, S., Ghesquiere, B., Hanna, M. G., Houlden, H., Lunn, M. P., Reilly, M. M., Milic Rasic, V., & Jordanova, A. (2026). Biallelic variants in COX18 cause a mitochondrial disorder primarily manifesting as peripheral neuropathy. Brain. https://doi.org/10.1093/brain/awaf300
Vancouver
Armirola-Ricaurte C, Morant L, Adant I, Hamed SA, Pipis M, Efthymiou S, et al. Biallelic variants in COX18 cause a mitochondrial disorder primarily manifesting as peripheral neuropathy. Brain. 2026. doi:10.1093/brain/awaf300
BibTeX
@article{ArmirolaRicaurte2026,
author = {Armirola-Ricaurte, Camila and Morant, Laura and Adant, Isabelle and Hamed, Sherifa A and Pipis, Menelaos and Efthymiou, Stephanie and Amor-Barris, Silvia and Atkinson, Derek and Van de Vondel, Liedewei and Tomic, Aleksandra and Seneca, Sara and de Vriendt, Els and Zuchner, Stephan and Ghesquiere, Bart and Hanna, Michael G and Houlden, Henry and Lunn, Michael P and Reilly, Mary M and Milic Rasic, Vedrana and Jordanova, Albena},
title = {Biallelic variants in COX18 cause a mitochondrial disorder primarily manifesting as peripheral neuropathy},
journal = {Brain},
year = {2026},
doi = {10.1093/brain/awaf300}
}
EUVIMED